Fendiline hydrochloride
CAS No. 13636-18-5
Fendiline hydrochloride( Fendiline Hydrochloride | Fendiline HCl )
Catalog No. M11498 CAS No. 13636-18-5
Fendiline is a nonselective calcium channel blocker.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | In Stock |
|
| 50MG | 31 | In Stock |
|
| 100MG | 44 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFendiline hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionFendiline is a nonselective calcium channel blocker.
-
DescriptionFendiline is a nonselective calcium channel blocker.
-
In Vitro——
-
In Vivo——
-
SynonymsFendiline Hydrochloride | Fendiline HCl
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorCalcium Channel
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number13636-18-5
-
Formula Weight351.91
-
Molecular FormulaC23H26ClN
-
Purity>98% (HPLC)
-
SolubilityWater: 10 mM
-
SMILESCC(NCCC(C1=CC=CC=C1)C2=CC=CC=C2)C3=CC=CC=C3.[H]Cl
-
Chemical Name3,3-Diphenyl-N-(1-phenylethyl)propan-1-amine hydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
SR33805
SR33805 is a potent antagonist of Ca2+ channel(EC50s of 4.1 nM and 33 nM in depolarized and polarized conditions, respectively)Acute treatment with SR33805 restored the MI-altered cell shortening without affecting the Ca(2+) transient amplitude, suggesting an increase of myofilament Ca(2+) sensitivity in MI myocytes.?
-
Ca2+ channel agonist...
Ca2+ channel agonist 1 is an agonist of N-type Ca2+ channel and an inhibitor of Cdk2 (EC50s: 14.23 μM and 3.34 μM) and is used as a potential treatment for motor nerve terminal dysfunction.
-
Levamlodipine
Levamlodipine also known as S-amlodipine is a pharmacologically active enantiomer of amlodipine an antihypertensive and anti-anginal medication.
Cart
sales@molnova.com